Insider Selling: HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Sells $11,053.96 in Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank sold 412 shares of HCA Healthcare stock in a transaction on Tuesday, April 3rd. The stock was sold at an average price of $26.83, for a total transaction of $11,053.96. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

HCA Healthcare Trading Down 0.0 %

HCA opened at $342.25 on Monday. The firm has a market cap of $84.26 billion, a P/E ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The stock has a 50-day moving average of $324.53 and a 200 day moving average of $340.92. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business earned $5.90 earnings per share. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is presently 13.11%.

Institutional Trading of HCA Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in HCA. Congress Wealth Management LLC DE increased its position in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after acquiring an additional 34 shares during the period. Evergreen Private Wealth LLC lifted its holdings in shares of HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after buying an additional 35 shares during the period. Mediolanum International Funds Ltd raised its holdings in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after acquiring an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. grew its holdings in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after acquiring an additional 40 shares in the last quarter. Finally, Whittier Trust Co. lifted its position in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after purchasing an additional 41 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Truist Financial reduced their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Morgan Stanley lowered their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Bank of America decreased their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Finally, Barclays cut their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.